- 英文名称(8R,9S,10R,13S,14S,17R)-3-Cyclopentyloxy-17-Ethynyl-13-Methyl-2,7,8,9,10,11,12,14,15,16-Decahydro-1H-Cyclopenta[a]Phenanthren-17-Ol
- 中文名称醋炔醚
- 其它别名19-Nor-17a-pregna-3,5-dien-20-yn-17-ol,3-(cyclopentyloxy)- (8CI); 3-(Cyclopentyloxy)-19-nor-17a-pregn-4-en-20-yn-17-ol; 3-(Cyclopentyloxy)-19-nor-17a-pregna-3,5-dien-20-yn-17-ol; Quingestanol
- CAS编号10592-65-1
- MFCD编号:MFCD09837736
- EINECS号:234-199-2
- FDA UNII编号:1A635076CE
- 分子式:C25H34O2分子量:366.54
- 产品CID: 99934
- 产品分类原料药 → 激素及调节内分泌功能类药 → 避孕药
- 相似结构搜索
- InChIKey: PCJFRMOEZQQSAX-AIOSZGMZSA-N
- 1S/C25H34O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,8,16,18,20-23,26H,4-7,9-15H2,2H3/t20-,21+,22+,23-,24-,25-/m0/s1
- 计算化学: 氢键受体数2.0氢键供体数1.0可旋转键数3.0
海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2905141000-异丁醇
2905142000-仲丁醇
2905191000-3,3-二甲基丁-2-醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-7186756-B2
优先权日:2003-07-25
标题 :Steroid derivatives and use thereof as medicaments
发明人:GUTIERREZ GILLES; SERRAR MOSTAFA; HADID ZOHRA
权利人:INOVAT SARL
摘要:Steroids of the formula n nwherein R is defined as in the application capable of increasing the synthesis of collagen.
专利号:US-2025281509-A1
优先权日:2021-04-26
标 题 :Sequential hormone therapy to improve survival and enhance response to immune therapy in men with prostate cancer
发明人:DENMEADE SAMUEL R; ISAACS JOHN T; ANTONARAKIS EMMANUEL S; KACHHAP SUSHANT; MARKOWSKI MARK CHRISTOPHER
权利人:UNIV JOHNS HOPKINS
摘要:Disclosed are methods for treating men with castrate resistant prostate cancer with a sufficient dose of testosterone to achieve supraphysiologic serum levels of testosterone in sequence with androgen ablative treatment or androgen synthesis inhibitors for one or more cycles until evidence of radiographic progression, at which point the subject will receive immune checkpoint blockade therapy.